How did Nephros' revenue and expenses shift in Q4 2024?

Nephros' financials for Q4 2024 show a positive revenue growth rate, but net income remains stable, with diluted EPS showing an increase due to a higher stock price, rather than improved profitability.

1. **Revenue Shift**:
- **Revenue Growth**: The total revenue for Nephros in Q4 2024 was $3.87 million, with a year-over-year growth rate of 0.19%.
- **Segmental Analysis**: The company's revenue is divided into two segments: Product and Royalty and Other. The Product segment contributed $3.25 million, while Royalty and Other contributed $127,000 and $106,000, respectively.
2. **Expense Shift**:
- **Net Income**: The net income for the quarter was $349,000. This indicates that the company's expenses, when combined with revenue, resulted in a net profit of this amount.
- **Diluted EPS**: The diluted EPS was $1.95, which represents an 8.33% increase from the previous period. This increase is due to the higher stock price rather than an improvement in earnings per share.

|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|NEPH|NEPH.O|Nephros|20240101-2024|Royalty and Other|127000|186|
|NEPH|NEPH.O|Nephros|20240101-2024|Royalty and Other|106000|186|
|NEPH|NEPH.O|Nephros|20240101-2024|Royalty and Other|60000|186|
|NEPH|NEPH.O|Nephros|20240101-2024|Royalty and Other|16000|186|
|NEPH|NEPH.O|Nephros|20240101-2024|Product|3506000|186|
|NEPH|NEPH.O|Nephros|20240101-2024|Royalty and Other|16000|186|

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|NEPH|NEPH.O|Nephros|2024 Q1|44.771241830065364|-169000|186|
|NEPH|NEPH.O|Nephros|2024 Q2|33.25635103926097|-289000|186|
|NEPH|NEPH.O|Nephros|2024 Q3|200.54945054945054|183000|186|
|NEPH|NEPH.O|Nephros|2024 Q4|153.3639143730887|349000|186|

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|NEPH|NEPH.O|Nephros|2024 Q1|33.33333333333333|-0.02|186|
|NEPH|NEPH.O|Nephros|2024 Q2|25.000000000000007|-0.03|186|
|NEPH|NEPH.O|Nephros|2024 Q3|200|0.02|186|

In conclusion, Nephros saw a slight increase in revenue, primarily driven by the Product segment, but net income remained relatively stable. The increase in diluted EPS is largely attributed to the rise in the company's stock price, not improved profitability.